Education
About Us
Working with TipRanks
Follow Us
Theratechnologies Inc (TSE:TH)
TSX:TH
Total Valuation
Theratechnologies has a market cap or net worth of $124.15M. The enterprise value is C$187.24M.
Market Cap$124.15M
Enterprise ValueC$187.24M
Share Statistics
Theratechnologies has 45,980,020 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,980,020
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Theratechnologies’s return on equity (ROE) is 0.33 and return on invested capital (ROIC) is 52.94%.
Return on Equity (ROE)0.33
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)52.94%
Return on Capital Employed (ROCE)0.50
Revenue Per Employee833.65K
Profits Per Employee-80.64K
Employee Count103
Asset Turnover1.61
Inventory Turnover3.87
Valuation Ratios
The current PE Ratio of Theratechnologies is -7.52. Theratechnologies’s PEG ratio is 0.09.
PE Ratio-7.52
PS Ratio0.85
PB Ratio-2.47
Price to Fair Value-2.47
Price to FCF71.09
Price to Operating Cash Flow26.27
PEG Ratio0.09
Income Statement
In the last 12 months, Theratechnologies had revenue of 85.87M and earned -8.31M in profits. Earnings per share was -0.16.
Revenue85.87M
Gross Profit65.42M
Operating Income8.17M
Pretax Income-6.30M
Net Income-8.31M
EBITDA6.88M
Earnings Per Share (EPS)-0.16
Cash Flow
In the last 12 months, operating cash flow was -5.66M and capital expenditures -11.60M, giving a free cash flow of -17.26M billion.
Operating Cash Flow-5.66M
Free Cash Flow-17.26M
Free Cash Flow per Share-0.38
Dividends & Yields
Theratechnologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change101.89%
50-Day Moving Average2.50
200-Day Moving Average2.11
Relative Strength Index (RSI)69.75
Average Volume (3m)124.33K
Important Dates
Theratechnologies upcoming earnings date is Jul 10, 2025, TBA Not Confirmed.
Last Earnings DateApr 9, 2025
Next Earnings DateJul 10, 2025
Ex-Dividend Date―
Financial Position
Theratechnologies as a current ratio of 1.19, with Debt / Equity ratio of -205.79%
Current Ratio1.19
Quick Ratio1.05
Debt to Market Cap0.71
Net Debt to EBITDA5.77
Interest Coverage Ratio0.78
Taxes
In the past 12 months, Theratechnologies has paid 2.00M in taxes.
Income Tax2.00M
Effective Tax Rate-0.32
Enterprise Valuation
Theratechnologies EV to EBITDA ratio is 14.86, with an EV/FCF ratio of 116.26.
EV to Sales1.19
EV to EBITDA14.86
EV to Free Cash Flow116.26
EV to Operating Cash Flow42.96
Balance Sheet
Theratechnologies has $4.34M in cash and marketable securities with $50.35M in debt, giving a net cash position of $46.01M billion.
Cash & Marketable Securities$4.34M
Total Debt$50.35M
Net Cash$46.01M
Net Cash Per Share$1.00
Tangible Book Value Per Share-$0.64
Margins
Gross margin is 78.97%, with operating margin of 9.52%, and net profit margin of -9.67%.
Gross Margin78.97%
Operating Margin9.52%
Pretax Margin-7.34%
Net Profit Margin-9.67%
EBITDA Margin8.01%
EBIT Margin4.80%
Analyst Forecast
The average price target for Theratechnologies is $4.15, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.15
Price Target Upside10.92% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast16.23%
EPS Growth Forecast85.76%